4Morozumi M,,Iwata S,Hasegawa K,et al.Increased macrolide resistance of Mycoplasma pneumoniae in pediatric patients with community -acquired pneumonia. Antimicrobial Agents and Chemotherapy . 2008 被引量:1
5Doern,GV.Antimicrobial use and the emergence of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clinical Infectious Diseases . 2001 被引量:1
7Dovern GV.Antimicrobial use and the emergence of antimicrobial resistance with streptococcus pneumoniae in the United States[J].Clin Infect Dis,2001,33(suppl 3):S187-192. 被引量:1
8Dolhoff A,Petersen U,Endermann R.In vitro activity of BAY 12-8039,a new 8-methoxyquinolo[J].Chemotherapy,1996,42:410-425. 被引量:1
9Andrews JM,Honeybourne D,Jevons G,et al.Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre optic bronchoscopy[J].J Antimicrob Chemother,1997,40:573-577. 被引量:1
10Soman A,Honeybourne D,Andrews J,et al.Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy[J].J Antimicrob Chemother,1999,44:835-838. 被引量:1